中藥小青龍湯的使用能降低小兒氣喘的住院率

Xiao Qing Ling Tang use may reduce the risk of hospitalization in children with asthma

施瑋泰(Ｗei-Tai Shih)

指導教授 ： 陳保中

國立臺灣大學/公共衛生學院/職業醫學與工業衛生研究所/碩士(2015年)

https://doi.org/10.6342/NTU.2015.01521

摘要

無資料

關鍵字

小青龍湯 ； 中藥 ； 氣喘 ； 小兒

並列摘要

Background:
Several animal studies have shown the therapeutic effect of Xiao Qing Long Tang (XQLT) in asthma. However, However, there is still no large clinical trial to prove the effect of XQLT in children with asthma. The purpose of this study was to investigate the association between XQLT use and asthma in children.
Methods:
We conducted a population-based cohort study by using the Taiwan National Health Insurance Research Database. A total of 21 415 children with asthma were included as the study cohort. A Cox proportional hazard regression was performed to evaluate the association between XQLT use and asthma admission risk.
Results:
The patients who recorded as XQLT users and nonusers were 2 281 and 19 134 in the unmatched cohort. In the matched cohort, a total of 2 197 users and 8 788 nonusers were included. After adjusted for the age, gender, severity, Allergic rhinitis, Atopic dermatitis, and urbanization, XQLT was independently associated with the decreased risk of admission for asthma with dose-response relationship. In the unmatched cohort, the hazard ratio(HRs) were 0.54 (95% confidence interval (CI) 0.36-0.81) in children who used XQLT 28 days or less and 0.34 (95% CI 0.21-0.55) in children who used XQLT more than 28 days, and were 0.53 (95% CI 0.34-0.82) and 0.34 (95% CI 0.21-0.56) in children who used XQLT 28 days or less and children who used XQLT more than 28 days in the matched cohort.
Conclusion:
In conclusion, XQLT use was associated with lower incidence of asthma admission in children with asthma. It may show the possible therapeutic application of XQLT in children with asthma. Further large-scale clinical study is needed.

並列關鍵字

Xiao Qing Long Tang (XQLT) ； traditional Chinese medicine (TCM) ； asthma ； children

參考文獻

1. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225–1232.

2. Li XM, Brown L. Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy. J Allergy Clin Immunol 2009;123:297–306.

5. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States. Natl Health Stat Report 2007;2008:1–23.

6. Kao ST, Chang CH, Chen YS, Chiang SY, Lin JG. Effects of Ding-Chuan-Tang on bronchoconstriction and airway leucocyte infiltration in sensitized guinea pigs. Immunopharmacol Immunotoxicol 2004;26:113–124.

7. Chan CK, Kuo ML, Shen JJ, See LC, Chang HH, Huang JL. Ding Chuan Tang, a Chinese herb decoction, could improve airway hyperresponsiveness in stabilized asthmatic children: a randomized, double-blind clinical trial. Pediatr Allergy Immunol 2006;17:316–322.